X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SUN PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SUN PHARMA J.B.CHEMICALS/
SUN PHARMA
 
P/E (TTM) x 19.5 24.8 78.4% View Chart
P/BV x 2.0 2.6 76.5% View Chart
Dividend Yield % 0.6 0.5 121.8%  

Financials

 J.B.CHEMICALS   SUN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
SUN PHARMA
Mar-18
J.B.CHEMICALS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs363701 51.8%   
Low Rs255433 58.9%   
Sales per share (Unadj.) Rs169.1110.4 153.2%  
Earnings per share (Unadj.) Rs16.611.0 151.2%  
Cash flow per share (Unadj.) Rs23.417.2 135.9%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.60.4 183.4%  
Book value per share (Unadj.) Rs172.5158.8 108.6%  
Shares outstanding (eoy) m83.572,399.26 3.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.85.1 35.6%   
Avg P/E ratio x18.651.6 36.1%  
P/CF ratio (eoy) x13.232.9 40.1%  
Price / Book Value ratio x1.83.6 50.2%  
Dividend payout %12.018.2 66.1%   
Avg Mkt Cap Rs m25,8271,360,021 1.9%   
No. of employees `0003.817.8 21.2%   
Total wages/salary Rs m2,51153,671 4.7%   
Avg. sales/employee Rs Th3,747.414,890.9 25.2%   
Avg. wages/employee Rs Th665.73,017.1 22.1%   
Avg. net profit/employee Rs Th367.81,480.6 24.8%   
INCOME DATA
Net Sales Rs m14,135264,895 5.3%  
Other income Rs m3668,388 4.4%   
Total revenues Rs m14,501273,282 5.3%   
Gross profit Rs m2,17856,081 3.9%  
Depreciation Rs m57014,998 3.8%   
Interest Rs m355,176 0.7%   
Profit before tax Rs m1,94044,295 4.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-9,505 0.0%   
Tax Rs m5528,452 6.5%   
Profit after tax Rs m1,38726,338 5.3%  
Gross profit margin %15.421.2 72.8%  
Effective tax rate %28.519.1 149.2%   
Net profit margin %9.89.9 98.7%  
BALANCE SHEET DATA
Current assets Rs m10,470316,359 3.3%   
Current liabilities Rs m2,749198,643 1.4%   
Net working cap to sales %54.644.4 122.9%  
Current ratio x3.81.6 239.1%  
Inventory Days Days5595 58.2%  
Debtors Days Days78108 72.1%  
Net fixed assets Rs m5,811213,178 2.7%   
Share capital Rs m1672,399 7.0%   
"Free" reserves Rs m14,248378,606 3.8%   
Net worth Rs m14,416381,006 3.8%   
Long term debt Rs m017,721 0.0%   
Total assets Rs m17,649643,028 2.7%  
Interest coverage x56.69.6 591.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 194.4%   
Return on assets %8.14.9 164.4%  
Return on equity %9.66.9 139.2%  
Return on capital %13.710.0 136.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16440,816 15.1%   
Fx outflow Rs m1,33430,143 4.4%   
Net fx Rs m4,82910,673 45.2%   
CASH FLOW
From Operations Rs m1,23139,072 3.1%  
From Investments Rs m-208-33,708 0.6%  
From Financial Activity Rs m-595-15,393 3.9%  
Net Cashflow Rs m427-7,359 -5.8%  

Share Holding

Indian Promoters % 55.4 63.7 87.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.1 66.1%  
FIIs % 3.9 23.0 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.3 445.8%  
Shareholders   30,437 133,026 22.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Hit Record High as Exit Polls Predict NDA Win; Sensex Ends 1,421 Points Higher(Closing)

Indian share markets witnessed huge buying interest today. The benchmark indices opened gap-up after Exit Polls for the Lok Sabha Elections 2019.

Related Views on News

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1% (Quarterly Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

For the quarter ended June 2018, SUN PHARMA has posted a net profit of Rs 11 bn (up 446.1% YoY). Sales on the other hand came in at Rs 72 bn (up 16.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

A 10-Bagger in Just 6 Years! The Rebirth of India Will Create More Big Winners Like This(The 5 Minute Wrapup)

May 7, 2019

How a niche tech startup battled all odds to eventually become a 10 bagger.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 20, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - GLENMARK PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS